The International Cannabis Business Conference (ICBC) came to Berlin this April 10-12, 2017, and brought the best of global cannabis expertise with it!
The event was unlike any other, and was an exclusive look into the most current and up-to-date happenings in Germany and Europe regarding cannabis policy, business, and perhaps most importantly, the science of medical cannabis.
The United States’ complete federal prohibition on marijuana has noticeably stymied the proliferation of quality cannabis research in the Western Hemisphere, state-approved investigations of the plant’s medical efficacy have been progressing for decades in many European countries.
The ICBC hosted an impressive list of medical professionals who have delved into the unique intersection of cannabis science and policy, and they are worth getting to know:
Dr. Franjo Grotenhermen, MD, founder and chairman of the German Association for Cannabis as Medicine (ACM), founder and executive director of the International Association for Cannabinoid Medicines (IACM) and chairman of the Medical Cannabis Declaration (MCD).
Dr. Pierre Debs, scientist with 25+ years academic research experience with genetic engineering, stem cell biology, somatic cell reprogramming and the endocannabinoid system.
Dr. Ingo Michels, MD, International Coordinator of the EU Central Asia Drug Action Programme (CADAP) at the University of Applied Sciences in Frankfurt on Main, Germany, as well as former Head of the Drugs and Prison projects department of the German AIDS-Hilfe in Berlin, former Drug Commissioner of the Federal State of Bremen, Germany, and former Head of the Office of the Federal Drug Commissioner, Federal Ministry of Health in Berlin.
Dr. Jokūbas Žiburkus, PhD, neuroscientist with over 20 peer-reviewed publications and book chapters, tenured Associate Professor at the University of Houston, and co-founder of CannTelligence,an educational and biotechnological innovation hub for cannabis industry-related projects.
Dr. Pavel Jeřábek, medical cannabis specialist and cannabis inspector for the Czech State Institute For Drug Control (SÚKL – State Agency for Medical Cannabis).
Dr. Pavel Kubů, MD, co-founder of the International Cannabis and Cannabinoids Institute (formerly known as Konomed), board member of the Czech National Forum for eHealth and Business Development Manager at Intel Corporation.
Ognjen Brborovic, PhD, author in 20+ scientific papers published in peer reviewed journals, former vice-president of Croatian Public Health Society, and President of the Minister Committee on Medical Cannabis in Croatia.
Susan Audino, PhD, owner and operator of a consulting firm to service chemical and biological laboratories, an A2LA Lead Assessor and Instructor, a Board Member for the Center for Research on Environmental Medicine in Maryland, and chair of the first AOAC Cannabis Working Group.